SunTrust Robinson Humphrey Downgrades ISTA Pharmaceuticals (ISTA) to Neutral
Tweet
Share
E-mailGet Alerts ISTA Hot Sheet
Price: $9.09 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
SunTrust Robinson Humphrey downgraded ISTA Pharmaceuticals (NASDAQ: ISTA) to Neutral.
For an analyst ratings summary and ratings history on ISTA Pharmaceuticals click here. For more ratings news on ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $3.89 yesterday.
For an analyst ratings summary and ratings history on ISTA Pharmaceuticals click here. For more ratings news on ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $3.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Monster Beverage (MNST) to Neutral, 'Cost Pressures and Weaker Low-end Consumer'
- Goldman Sachs Downgrades Parade Technologies Ltd. (4966:TT) to Sell
- JPMorgan Downgrades Beijing Easpring Material Technology Co Ltd. (300073:CH) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
